Susquehanna International Group
CALA

Susquehanna International Group’s Calithera Biosciences, Inc CALA Stock Holding History

Susquehanna International Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,177
Closed -$25K – 14880
2022
Q2 		$25K Buy
+10,177
New +$47.2K ﹤0.01% 12307
2022
Q1 		– Sell
-2,348
Closed -$24K – 14487
2021
Q4 		$31K Buy
+2,348
New +$59K ﹤0.01% 12742
2021
Q3 		– Sell
-5,513
Closed -$238K – 13949
2021
Q2 		$230K Sell
5,513
-7,576
-58% -$333K ﹤0.01% 11305
2021
Q1 		$633K Sell
13,089
-202
-2% -$11.8K ﹤0.01% 8920
2020
Q4 		$1.3M Buy
+13,291
New +$1.16M ﹤0.01% 6064
2020
Q3 		– Sell
-2,213
Closed -$234K – 11391
2020
Q2 		$234K Buy
2,213
+943
+74% +$112K ﹤0.01% 8774
2020
Q1 		$113K Sell
1,270
-873
-41% -$104K ﹤0.01% 9236
2019
Q4 		$245K Sell
2,143
-641
-23% -$48.2K ﹤0.01% 8399
2019
Q3 		$172K Buy
2,784
+1,280
+85% +$102K ﹤0.01% 9231
2019
Q2 		$117K Sell
1,504
-383
-20% -$43.5K ﹤0.01% 9533
2019
Q1 		$254K Sell
1,887
-3,193
-63% -$335K ﹤0.01% 7506
2018
Q4 		$407K Buy
5,080
+29
+0.6% +$2.86K ﹤0.01% 6411
2018
Q3 		$530K Sell
5,051
-6,482
-56% -$617K ﹤0.01% 6406
2018
Q2 		$1.15M Sell
11,533
-7,583
-40% -$859K ﹤0.01% 5039
2018
Q1 		$2.41M Buy
19,116
+11,902
+165% +$1.86M ﹤0.01% 3580
2017
Q4 		$1.21M Buy
+7,214
New +$1.85M ﹤0.01% 4872
2017
Q2 		– Sell
-5,475
Closed -$1.46M – 10060
2017
Q1 		$1.26M Buy
5,475
+1,747
+47% +$302K ﹤0.01% 4633
2016
Q4 		$242K Buy
3,728
+2,379
+176% +$149K ﹤0.01% 8352
2016
Q3 		$88K Sell
1,349
-6
-0.4% -$387 ﹤0.01% 7989
2016
Q2 		$101K Buy
+1,355
New +$136K ﹤0.01% 8015
2015
Q4 		– Sell
-1,259
Closed -$189K – 10182
2015
Q3 		$137K Buy
1,259
+519
+70% +$67.3K ﹤0.01% 8973
2015
Q2 		$106K Buy
+740
New +$172K ﹤0.01% 9645
2015
Q1 		– Sell
-726
Closed -$293K – 10113
2014
Q4 		$293K Buy
+726
New +$190K ﹤0.01% 8176

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's CALA Position: Q3 2022 in Review

Susquehanna International Group sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 10,177 shares — an estimated $25K sold.

Susquehanna International Group first reported a position in CALA in Q4 2014 and held it in 23 quarters. The position peaked at $2.41M in Q1 2018. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

  • Susquehanna International Group reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 10,177 Calithera Biosciences, Inc shares in Q3 2022, an estimated $25K.
  • Susquehanna International Group first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 23 quarters.
  • Susquehanna International Group's Calithera Biosciences, Inc position peaked at $2.41M in Q1 2018.
  • 22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.